{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:25:09Z","timestamp":1776770709938,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer US","isbn-type":[{"value":"9781071619230","type":"print"},{"value":"9781071619247","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1924-7_15","type":"book-chapter","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T22:02:37Z","timestamp":1646258557000},"page":"257-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Fluorescence-Based In Vitro Method to Assess Cholesterol Efflux"],"prefix":"10.1007","author":[{"given":"Sara","family":"Fern\u00e1ndez-Castillejo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pedret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00darsula","family":"Catal\u00e1n Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1373\/clinchem.2016.257725","volume":"63","author":"SK Karathanasis","year":"2017","unstructured":"Karathanasis SK, Freeman LA, Gordon SM, Remaley AT (2017) The changing face of HDL and the best way to measure it. Clin Chem 63:196\u2013210. https:\/\/doi.org\/10.1373\/clinchem.2016.257725","journal-title":"Clin Chem"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","volume":"114","author":"TF L\u00fcscher","year":"2014","unstructured":"L\u00fcscher TF, Landmesser U, Von Eckardstein A, Fogelman AM (2014) High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res 114:171\u2013182. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.300935","journal-title":"Circ Res"},{"issue":"Suppl","key":"15_CR3","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","volume":"50","author":"K-A Rye","year":"2009","unstructured":"Rye K-A, Bursill CA, Lambert G et al (2009) The metabolism and anti-atherogenic properties of HDL. J Lipid Res 50(Suppl):S195\u2013S200. https:\/\/doi.org\/10.1194\/jlr.R800034-JLR200","journal-title":"J Lipid Res"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-319-09665-0","volume":"224","author":"E Favari","year":"2015","unstructured":"Favari E, Chroni A, Tietge UJFF et al (2015) Cholesterol efflux and reverse cholesterol transport. Handb Exp Pharmacol 224:181\u2013206. https:\/\/doi.org\/10.1007\/978-3-319-09665-0","journal-title":"Handb Exp Pharmacol"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M et al (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa1001689","journal-title":"N Engl J Med"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2016.07.005","volume":"180","author":"M Anastasius","year":"2016","unstructured":"Anastasius M, Kockx M, Jessup W et al (2016) Cholesterol efflux capacity: an introduction for clinicians. Am Heart J 180:1\u201310. https:\/\/doi.org\/10.1016\/j.ahj.2016.07.005","journal-title":"Am Heart J"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","volume":"3","author":"D Saleheen","year":"2015","unstructured":"Saleheen D, Scott R, Javad S et al (2015) Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. Lancet Diabetes Endocrinol 3:507\u2013513. https:\/\/doi.org\/10.1016\/S2213-8587(15)00126-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.2174\/0929867323666160809093009","volume":"23","author":"D Litvinov","year":"2016","unstructured":"Litvinov D, Savushkin E, Garaeva E, Dergunov A (2016) Cholesterol efflux and reverse cholesterol transport: experimental approaches. Curr Med Chem 23:3883\u20133908. https:\/\/doi.org\/10.2174\/0929867323666160809093009","journal-title":"Curr Med Chem"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-4939-2929-0","volume":"1339","author":"JC Escol\u00e0-Gil","year":"2015","unstructured":"Escol\u00e0-Gil JC, Lee-Rueckert M, Santos D et al (2015) Quantification of in vitro macrophage cholesterol efflux and in vivo macrophage-specific reverse cholesterol transport. Methods Mol Biol 1339:211\u2013233. https:\/\/doi.org\/10.1007\/978-1-4939-2929-0","journal-title":"Methods Mol Biol"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pcad.2015.05.004","volume":"58","author":"A Rohatgi","year":"2015","unstructured":"Rohatgi A (2015) High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity. Prog Cardiovasc Dis 58:32\u201340. https:\/\/doi.org\/10.1016\/j.pcad.2015.05.004","journal-title":"Prog Cardiovasc Dis"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1194\/jlr.D018051","volume":"52","author":"S Sankaranarayanan","year":"2011","unstructured":"Sankaranarayanan S, Kellner-Weibel G, de la Llera-Moya M et al (2011) A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol. J Lipid Res 52:2332\u20132340. https:\/\/doi.org\/10.1194\/jlr.D018051","journal-title":"J Lipid Res"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","volume":"48","author":"MP Adorni","year":"2007","unstructured":"Adorni MP, Zimetti F, Billheimer JT et al (2007) The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res 48:2453\u20132462. https:\/\/doi.org\/10.1194\/jlr.M700274-JLR200","journal-title":"J Lipid Res"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","volume":"50","author":"S Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan S, Oram JF, Asztalos BF et al (2009) Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux. J Lipid Res 50:275\u2013284. https:\/\/doi.org\/10.1194\/jlr.M800362-JLR200","journal-title":"J Lipid Res"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/adt.2010.0288","volume":"9","author":"J Zhang","year":"2011","unstructured":"Zhang J, Cai S, Peterson BR et al (2011) Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol. Assay Drug Dev Technol 9:136\u2013146. https:\/\/doi.org\/10.1089\/adt.2010.0288","journal-title":"Assay Drug Dev Technol"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1038\/jid.2014.371","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD et al (2014) HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 371:2383\u20132393. https:\/\/doi.org\/10.1038\/jid.2014.371","journal-title":"N Engl J Med"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/01.ATV.14.7.1056","volume":"14","author":"MM de la Llera","year":"1994","unstructured":"de la Llera MM, Atger V, Paul JL et al (1994) A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 14:1056\u20131065. https:\/\/doi.org\/10.1161\/01.ATV.14.7.1056","journal-title":"Arterioscler Thromb"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB, Ansell BJ et al (2016) Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 13:48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124","journal-title":"Nat Rev Cardiol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1194\/jlr.M041038","volume":"55","author":"O Miyazaki","year":"2014","unstructured":"Miyazaki O, Ogihara J, Fukamachi I, Kasumi T (2014) Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma. J Lipid Res 55:214\u2013225. https:\/\/doi.org\/10.1194\/jlr.M041038","journal-title":"J Lipid Res"},{"key":"15_CR19","first-page":"659","volume":"45","author":"A Hafiane","year":"2015","unstructured":"Hafiane A, Genest J (2015) HDL-mediated cellular cholesterol efflux assay method. Ann Clin Lab Sci 45:659\u2013668","journal-title":"Ann Clin Lab Sci"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1111\/j.1600-0854.2008.00801.x","volume":"9","author":"M H\u00f6ltt\u00e4-Vuori","year":"2008","unstructured":"H\u00f6ltt\u00e4-Vuori M, Uronen RL, Repakova J et al (2008) BODIPY-cholesterol: a new tool to visualize sterol trafficking in living cells and organisms. Traffic 9:1839\u20131849. https:\/\/doi.org\/10.1111\/j.1600-0854.2008.00801.x","journal-title":"Traffic"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/cbic.201402042","volume":"15","author":"Z Liu","year":"2014","unstructured":"Liu Z, Thacker SG, Fernandez-Castillejo S et al (2014) Synthesis of cholesterol analogues bearing BODIPY fluorophores by Suzuki or Liebeskind-Srogl cross-coupling and evaluation of their potential for visualization of cholesterol pools. Chembiochem 15:2087\u20132096. https:\/\/doi.org\/10.1002\/cbic.201402042","journal-title":"Chembiochem"}],"container-title":["Methods in Molecular Biology","Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1924-7_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T01:12:51Z","timestamp":1650589971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1924-7_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071619230","9781071619247"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1924-7_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"2 March 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}